May 3rd 2024
At 12 months, the rate of IBD-related surgeries for the monitored group was 1% versus 7% for the control group.
Entyvio Found To Be Effective at Relieving Chronic Pouchitis After UC Surgery
April 19th 2023Patients treated with the gut-selective monoclonal antibody were three times more likely to achieve remission of inflammation of ileal pouch-anal anastomosis, an alternative to a life-long colostomy bag after colectomy.
Read More
University of Miami Researchers Receive $2.9 Million to Study IBD Genetics in Hispanic Population
February 3rd 2023Research by Maria T. Abreu, M.D., and Jacob McCauley, Ph.D., should help fill a gap in the research of the genetics of inflammatory bowel disease, including ulcerative colitis.
Read More
For Ulcerative Colitis, Two First-In-Class Candidates and an Interleukin-23 Competition
February 1st 2023A Swedish and a French company have treatments with novel mechanisms of action in late-stage development. Meanwhile, AbbVie, Janssen and Eli Lilly are vying to get the first interleukin-23 inhibitor for ulcerative colitis on the market.
Read More